Competing endogenous RNA networks reveal long non-coding RNAs as potential prognostic biomarkers in gastric cancer: A systematic review and meta-analysis

Aims: Gastric cancer (GC) represents a global health-care challenge. In recent years, a large number of competing endogenous RNA (ceRNA) network studies have elucidated critical long non-coding RNAs (lncRNAs) as potential prognostic biomarkers in GC. Nevertheless, there is no systematic review and meta-analysis regarding them. Here, we propose a systematic review and meta-analysis for lncRNAs as prognostic biomarkers based on the ceRNA network studies in GC. Main methods: The Web of Science, Embase, PubMed, Scopus, ProQuest and Google Scholar databases were searched to collect eligible ceRNA network studies in which lncRNAs were reported as prognostic biomarkers until 27th June 2022. The pooled hazard ratios (HRs) were assessed to evaluate the prognostic effect of the lncRNAs. Prognostic values of highly reported lncRNAs were also examined. Furthermore, sensitivity analysis, and publication bias were evaluated. Key findings: Totally, 35 studies were included in the systematic review among which 13 studies were eligible for meta-analysis. Pooled examination of HRs based on the univariate and multivariate reports revealed that the expression changes of the lncRNAs correlate with overall survival (OS) of GC patients. Two lncRNAs including CCDC144NL-AS1 and LINC01094 were highly reported as potential prognostic biomarkers based on the ceRNA network studies. Prognostic value of these two lncRNAs was furthermore confirmed by meta-analysis. Significance: Our meta-analysis demonstrated potential application of lncRNAs introduced based on the ceRNA network studies as promising prognostic biomarkers in GC. Further functional studies are needed to elucidate the molecular mechanisms underlying these lncRNAs' functions in GC.

[1]  Nuoya Yu,et al.  LncRNA LINC01094 Promotes Cells Proliferation and Metastasis through the PTEN/AKT Pathway by Targeting AZGP1 in Gastric Cancer , 2023, Cancers.

[2]  Yong Li,et al.  Potential upstream lncRNA–miRNA–mRNA regulatory network of the ferroptosis-related gene SLC7A11 in renal cell carcinoma , 2023, Translational andrology and urology.

[3]  Mo-pei Wang,et al.  Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy , 2022, Biomarker research.

[4]  D. Bentrem,et al.  Environmental and genetic risk factors for gastric cancer , 2022, Journal of surgical oncology.

[5]  J. Y. Xia,et al.  Advances in screening and detection of gastric cancer , 2022, Journal of surgical oncology.

[6]  Qingchun Cai,et al.  LINC00922 acts as a novel oncogene in gastric cancer , 2022, World Journal of Surgical Oncology.

[7]  H. Su,et al.  Upregulated long intergenic non-protein coding RNA 1094 (LINC01094) is linked to poor prognosis and alteration of cell function in colorectal cancer , 2022, Bioengineered.

[8]  Xinkui Liu,et al.  A New Strategy to Identify ceRNA-Based CCDC144NL-AS1/SERPINE1 Regulatory Axis as a Novel Prognostic Biomarker for Stomach Adenocarcinoma via High Throughput Transcriptome Data Mining and Computational Verification , 2022, Frontiers in Oncology.

[9]  Zhaohui S. Qin,et al.  UALCAN: An update to the integrated cancer data analysis platform , 2022, Neoplasia.

[10]  J. Ji,et al.  Novel prognostic marker LINC00205 promotes tumorigenesis and metastasis by competitively suppressing miRNA-26a in gastric cancer , 2022, Cell death discovery.

[11]  Yuejiao Zhong,et al.  Revealing the Role of lncRNA CCDC144NL-AS1 and LINC01614 in Gastric Cancer via Integrative Bioinformatics Analysis and Experimental Validation , 2022, Frontiers in Oncology.

[12]  J. Eucker,et al.  LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration , 2022, Technology in cancer research & treatment.

[13]  Jun Lyu,et al.  Recent Estimates and Predictions of 5-Year Survival in Patients with Gastric Cancer: A Model-Based Period Analysis , 2022, Cancer control : journal of the Moffitt Cancer Center.

[14]  Yue Zhang,et al.  Long non-coding RNA CCDC144NL-AS1 promotes cell proliferation by regulating the miR-363-3p/GALNT7 axis in colorectal cancer , 2022, Journal of Cancer.

[15]  Fachao Zhi,et al.  Identification and Validation of a Potent Multi-lncRNA Molecular Model for Predicting Gastric Cancer Prognosis , 2021, Frontiers in Genetics.

[16]  Shuyan Zhang,et al.  Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer , 2021, Disease markers.

[17]  I. Oda,et al.  Epidemiological Trends and Future Perspectives of Gastric Cancer in Eastern Asia , 2021, Digestion.

[18]  Xiaojian Zhu,et al.  LINC01094 promotes pancreatic cancer progression by sponging miR-577 to regulate LIN28B expression and the PI3K/AKT pathway , 2021, Molecular therapy. Nucleic acids.

[19]  T. Winder,et al.  Advanced Gastric Cancer: Current Treatment Landscape and a Future Outlook for Sequential and Personalized Guide: Swiss Expert Statement Article , 2021, Oncology Research and Treatment.

[20]  Y. Kang,et al.  Hypoxia associated lncRNA HYPAL promotes proliferation of gastric cancer as ceRNA by sponging miR-431-5p to upregulate CDK14 , 2021, Gastric Cancer.

[21]  A. Lánczky,et al.  Web-Based Survival Analysis Tool Tailored for Medical Research (KMplot): Development and Implementation , 2021, Journal of medical Internet research.

[22]  C. Jin,et al.  LncRNA CCDC144NL-AS1 Serves as a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting miR-490-3p , 2021, Molecular Biotechnology.

[23]  Jitao Wang,et al.  Bioinformatic and integrated analysis identifies an lncRNA–miRNA–mRNA interaction mechanism in gastric adenocarcinoma , 2021, Genes & Genomics.

[24]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[25]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[26]  Yongning Zhou,et al.  Construction of a novel ceRNA network and identification of lncRNA ADAMTS9-AS2 and PVT1 as hub regulators of miRNA and coding gene expression in gastric cancer , 2021, Translational cancer research.

[27]  F. Teng,et al.  LncRNA NKX2‐1‐AS1 promotes tumor progression and angiogenesis via upregulation of SERPINE1 expression and activation of the VEGFR‐2 signaling pathway in gastric cancer , 2021, Molecular oncology.

[28]  Hongguang Song,et al.  Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis , 2021, Bioengineered.

[29]  Zhong Luo,et al.  Long Non-coding RNAs in Cancer: Implications for Diagnosis, Prognosis, and Therapy , 2020, Frontiers in Medicine.

[30]  Qian Liu,et al.  Development and validation of a novel prognostic signature in gastric adenocarcinoma. , 2020, Aging.

[31]  Jian Sun,et al.  Identification of a competing endogenous RNA axis related to gastric cancer , 2020, Aging.

[32]  Ping Zhang,et al.  LINC01094/miR-577 axis regulates the progression of ovarian cancer , 2020, Journal of Ovarian Research.

[33]  G. Shan,et al.  The physiological function of long-noncoding RNAs , 2020, Non-coding RNA Research.

[34]  Yufeng Liu,et al.  A novel ceRNA axis involves in regulating immune infiltrates and macrophage polarization in gastric cancer. , 2020, International immunopharmacology.

[35]  Zhen Li,et al.  The Somatic Mutation Landscape and RNA Prognostic Markers in Stomach Adenocarcinoma , 2020, OncoTargets and therapy.

[36]  Lianmin Ye,et al.  Identification of lncRNA-associated competing endogenous RNA networks for occurrence and prognosis of gastric carcinoma , 2020 .

[37]  H. Fan,et al.  Long non-coding RNA CCDC144NL-AS1 sponges miR-143-3p and regulates MAP3K7 by acting as a competing endogenous RNA in gastric cancer , 2020, Cell Death & Disease.

[38]  S. Ning,et al.  Long noncoding RNAs in gastric cancer: From molecular dissection to clinical application , 2020, World journal of gastroenterology.

[39]  Jin Zhang,et al.  The prognostic value of COL3A1/FBN1/COL5A2/SPARC-mir-29a-3p-H19 associated ceRNA network in Gastric Cancer through bioinformatic exploration , 2020, Journal of Cancer.

[40]  Zhengkai Huang,et al.  Gastric cancer risk-scoring system based on analysis of a competing endogenous RNA network , 2020, Translational cancer research.

[41]  Qingqiang Yang,et al.  H19 promotes the gastric carcinogenesis by sponging miR-29a-3p: evidence from lncRNA-miRNA-mRNA network analysis. , 2020, Epigenomics.

[42]  Lili Wang,et al.  Comprehensive analysis of competitive endogenous RNAs network reveals potential prognostic lncRNAs in gastric cancer , 2020, Heliyon.

[43]  Tong Li,et al.  Competing endogenous RNA network analysis reveals potential long non-coding RNAs as predictive biomarkers of gastric cancer , 2020, Oncology letters.

[44]  Fangzhou Song,et al.  Comprehensive Analysis of lncRNAs Associated with the Pathogenesis and Prognosis of Gastric Cancer. , 2020, DNA and cell biology.

[45]  Fan Li,et al.  Integrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer , 2020, Cancer medicine.

[46]  Dazhi Xu,et al.  Construction of a Competitive Endogenous RNA Network and Identification of Potential Regulatory Axis in Gastric Cancer , 2019, Front. Oncol..

[47]  Fangzhou Song,et al.  Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data , 2019, Journal of cellular biochemistry.

[48]  Jue Yang,et al.  Identification of long noncoding RNA RP11-169F17.1 and RP11-669N7.2 as novel prognostic biomarkers of stomach adenocarcinoma based on integrated bioinformatics analysis. , 2019, Epigenomics.

[49]  Xin Dong,et al.  Construction and analysis of lncRNA-associated ceRNA network identified potential prognostic biomarker in gastric cancer , 2019, Translational cancer research.

[50]  W. Zhuo,et al.  Emerging roles of lncRNA in cancer and therapeutic opportunities. , 2019, American journal of cancer research.

[51]  Zemin Zhang,et al.  GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..

[52]  Alexander Lachmann,et al.  Mining data and metadata from the gene expression omnibus , 2018, Biophysical Reviews.

[53]  Prashanth Rawla,et al.  Epidemiology of gastric cancer: global trends, risk factors and prevention , 2018, Przeglad gastroenterologiczny.

[54]  Qiang Wang,et al.  Comprehensive bioinformatics analysis of lncRNAs in gastric cancer. , 2018, Oncology letters.

[55]  Yi Zhu,et al.  Investigating Potential Molecular Mechanisms of Carcinogenesis and Genes as Biomarkers for Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis , 2018, Pathology & Oncology Research.

[56]  Xian Jiang,et al.  A Novel LncRNA-miRNA-mRNA Triple Network Identifies LncRNA RP11-363E7.4 as An Important Regulator of miRNA and Gene Expression in Gastric Cancer , 2018, Cellular Physiology and Biochemistry.

[57]  G. Arunkumar,et al.  Comprehensive analysis of aberrantly expressed lncRNAs and construction of ceRNA network in gastric cancer , 2018, Oncotarget.

[58]  Chao Sun,et al.  miR-103/107 promote ER stress-mediated apoptosis via targeting the Wnt3a/β-catenin/ATF6 pathway in preadipocytes , 2018, Journal of Lipid Research.

[59]  Maite Huarte,et al.  The multidimensional mechanisms of long noncoding RNA function , 2017, Genome Biology.

[60]  Hong Jin,et al.  Expression profiles analysis reveals an integrated miRNA-lncRNA signature to predict survival in ovarian cancer patients with wild-type BRCA1/2 , 2017, Oncotarget.

[61]  Zhi-yi Zhang,et al.  Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer. , 2016, International journal of oncology.

[62]  W. Schulz,et al.  Long noncoding RNAs in gastric cancer carcinogenesis and metastasis. , 2016, Briefings in functional genomics.

[63]  Paul L. Roebuck,et al.  TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer. , 2015, Cancer research.

[64]  K. Tomczak,et al.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge , 2015, Contemporary oncology.

[65]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[66]  P. Pandolfi,et al.  A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language? , 2011, Cell.

[67]  C. Begg,et al.  Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.

[68]  Zunnan Huang,et al.  Bioinformatics analysis of potential Key lncRNA-miRNA-mRNA molecules as prognostic markers and important ceRNA axes in gastric cancer. , 2022, American journal of cancer research.

[69]  C. Tufanaru,et al.  Chapter 7: Systematic Reviews of Etiology and Risk , 2020, JBI Manual for Evidence Synthesis.

[70]  Wei Wang,et al.  Identification of potential prognostic biomarkers for gastric adenocarcinoma by constructing competing endogenous RNA network , 2019 .

[71]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..